CytomX Therapeutics, Inc. (CTMX)
5.61
+0.18
(+3.31%)
USD |
NASDAQ |
Feb 23, 13:42
CytomX Therapeutics Price : 5.61 for Feb. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| REGENXBIO, Inc. | 7.91 |
| ACADIA Pharmaceuticals, Inc. | 24.28 |
| Alnylam Pharmaceuticals, Inc. | 331.19 |
| Savara, Inc. | 5.645 |
| BioMarin Pharmaceutical, Inc. | 64.62 |
Price Related Metrics
| PE Ratio | 13.41 |
| PS Ratio | 5.694 |
| PEG Ratio | 0.0915 |
| Price to Book Value | 8.851 |
| Earnings Yield | 7.45% |
| Market Cap | 950.53M |
| PEGY Ratio | 0.0915 |
| Operating PE Ratio | 27.95 |
| Normalized PE Ratio | 13.43 |